“The Centers for Disease Control and Prevention’s independent advisory committee has given the green light for Pfizer and BioNTech COVID-19 booster shots to be given to children ages 5 to 11 years old,” ABC News reports.
The FDA gave COVID-19 boosters for children ages 5 to 11 a green light on Tuesday, so this comes as zero surprise.
Children could receive booster doses as early as Friday morning.
At this point, it’s clearer than ever that the public health agencies operate as the purse for Big Pharma.
BREAKING: Scientific advisers to the CDC have recommended a booster dose of the Pfizer-BioNTech vaccine for children ages 5 to 11.https://t.co/D9b1Oe51Q5
— Apoorva Mandavilli (@apoorva_nyc) May 19, 2022
The CDC panel recommended that children 5-11 get "boosted" for Covid-19. There was one "No" vote.https://t.co/iN3rL4tZ44
— Kyle Becker (@kylenabecker) May 19, 2022
From ABC News:
The panel voted 11-1-1 in favor of approval. CDC Director Dr. Rochelle Walensky is expected to make the final signoff to recommend the shots shortly.
“We have the tools we need to protect these people from severe disease, and to prevent any more tragic deaths,” Walensky said during brief remarks at the beginning of the meeting. “It’s important for us to anticipate where this pandemic is moving and deploy the tools we have where they will have the greatest impact.”
Earlier this week, the Food and Drug Administration authorized the use of the booster shots among younger children to be used at least five months after completing their first round of shots.
Children over the age of 5 became eligible for vaccination against COVID-19 in November, so the first kids who were in line for their shot have now had about six months of protection.
Pfizer asked the FDA in April to authorize its booster vaccines for younger children, after it submitted data that indicated their shot was safe and generated a strong immune response.
Vaccine effectiveness after two doses against symptomatic infection “quickly declined for children and adolescents during omicron,” Dr. Ruth Link-Gelles, who leads the COVID-19 Vaccine Effectiveness program for the CDC’s Epidemiology Task Force, said on Thursday. A booster dose in adolescents significantly improved effectiveness — up to 71% — in the weeks and months after receiving the third dose.
While the CDC’s advisory committee approved COVID-19 boosters for young children, the agency’s own data shows vaccinated children as more likely to contract COVID.